Cardiovascular

ACHIEVE-4: WHAT THE MORTALITY SIGNAL ACTUALLY TELLS UK CLINICIANS

This week’s headline result is also this week's most over-hyped: 57% lower all-cause mortality with orforglipron compared to insulin glargine, and what these findings actually mean.